| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.7 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.02 | 0.7 |